肿瘤药-话题@MedSci

#肿瘤药#

125篇内容 | 3470人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1537691, encodeId=18ac153e69134, content=<a href='/topic/show?id=1f9983082fa' target=_blank style='color:#2F92EE;'>#肿瘤药#</a>, objectTitle=CFDA官网干货：抗肿瘤药物临床试验重要终点指标, objectType=article, longId=111435, objectId=4859111435d4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4859111435d4, replyNumber=0, likeNumber=74, createdTime=2017-09-01, rootId=0, userName=30397608, userId=ed1012894470, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4859111435d4, moduleTitle=CFDA官网干货：抗肿瘤药物临床试验重要终点指标, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4859111435d4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1537690, encodeId=0379153e690e8, content=<a href='/topic/show?id=1f9983082fa' target=_blank style='color:#2F92EE;'>#肿瘤药#</a>, objectTitle=2022年畅销的抗肿瘤药物TOP10, objectType=article, longId=101362, objectId=72d610136280, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=72d610136280, replyNumber=0, likeNumber=75, createdTime=2017-06-11, rootId=0, userName=30397608, userId=ed1012894470, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=72d610136280, moduleTitle=2022年畅销的抗肿瘤药物TOP10, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=72d610136280)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1537689, encodeId=ae6b153e689cc, content=<a href='/topic/show?id=1f9983082fa' target=_blank style='color:#2F92EE;'>#肿瘤药#</a>, objectTitle=Sci Rep：朱诗国团队提出抗肿瘤药物研发的新思路, objectType=article, longId=98001, objectId=8db298001d9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8db298001d9, replyNumber=0, likeNumber=126, createdTime=2017-05-07, rootId=0, userName=30397608, userId=ed1012894470, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8db298001d9, moduleTitle=Sci Rep：朱诗国团队提出抗肿瘤药物研发的新思路, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8db298001d9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1537688, encodeId=09eb153e68866, content=<a href='/topic/show?id=1f9983082fa' target=_blank style='color:#2F92EE;'>#肿瘤药#</a>, objectTitle=Oncotarget：维生素C抗癌活力竟是肿瘤药物的十倍！, objectType=article, longId=92513, objectId=2fe292513a2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2fe292513a2, replyNumber=0, likeNumber=87, createdTime=2017-03-22, rootId=0, userName=30397608, userId=ed1012894470, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2fe292513a2, moduleTitle=Oncotarget：维生素C抗癌活力竟是肿瘤药物的十倍！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2fe292513a2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1537687, encodeId=6c43153e68715, content=<a href='/topic/show?id=1f9983082fa' target=_blank style='color:#2F92EE;'>#肿瘤药#</a>, objectTitle=抗肿瘤药物的时间“罗盘”, objectType=article, longId=92210, objectId=eec192210cb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=eec192210cb, replyNumber=0, likeNumber=70, createdTime=2017-03-19, rootId=0, userName=30397608, userId=ed1012894470, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=eec192210cb, moduleTitle=抗肿瘤药物的时间“罗盘”, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=eec192210cb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1537686, encodeId=1a6c153e686c7, content=<a href='/topic/show?id=1f9983082fa' target=_blank style='color:#2F92EE;'>#肿瘤药#</a>, objectTitle=这个肿瘤药那么好，研发公司创始人却被投进大牢！, objectType=article, longId=90063, objectId=f3319006361, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f3319006361, replyNumber=0, likeNumber=71, createdTime=2017-02-28, rootId=0, userName=30397608, userId=ed1012894470, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f3319006361, moduleTitle=这个肿瘤药那么好，研发公司创始人却被投进大牢！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f3319006361)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1537685, encodeId=40e8153e68561, content=<a href='/topic/show?id=1f9983082fa' target=_blank style='color:#2F92EE;'>#肿瘤药#</a>, objectTitle=【数图说】国内外抗肿瘤药销售市场一览, objectType=article, longId=88816, objectId=a4ee888166c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a4ee888166c, replyNumber=0, likeNumber=59, createdTime=2017-02-16, rootId=0, userName=30397608, userId=ed1012894470, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a4ee888166c, moduleTitle=【数图说】国内外抗肿瘤药销售市场一览, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a4ee888166c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1537684, encodeId=1f0c153e68460, content=<a href='/topic/show?id=1f9983082fa' target=_blank style='color:#2F92EE;'>#肿瘤药#</a>, objectTitle=Adv Healthc Mater：开发出磁控干细胞用于肿瘤药物靶向输送, objectType=article, longId=86714, objectId=250186e14f7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=250186e14f7, replyNumber=0, likeNumber=74, createdTime=2017-01-07, rootId=0, userName=30397608, userId=ed1012894470, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=250186e14f7, moduleTitle=Adv Healthc Mater：开发出磁控干细胞用于肿瘤药物靶向输送, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=250186e14f7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1537683, encodeId=493e153e6838c, content=<a href='/topic/show?id=1f9983082fa' target=_blank style='color:#2F92EE;'>#肿瘤药#</a>, objectTitle=The Lancent oncology：所有仿制的抗肿瘤药都安全吗？, objectType=article, longId=82021, objectId=25f182021e4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=25f182021e4, replyNumber=0, likeNumber=72, createdTime=2016-11-11, rootId=0, userName=30397608, userId=ed1012894470, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=25f182021e4, moduleTitle=The Lancent oncology：所有仿制的抗肿瘤药都安全吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=25f182021e4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1537682, encodeId=6a14153e68273, content=<a href='/topic/show?id=1f9983082fa' target=_blank style='color:#2F92EE;'>#肿瘤药#</a>, objectTitle=NEJM：抗肿瘤药心脏毒性十五要点, objectType=article, longId=81980, objectId=cc11819802a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cc11819802a, replyNumber=0, likeNumber=66, createdTime=2016-11-10, rootId=0, userName=30397608, userId=ed1012894470, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cc11819802a, moduleTitle=NEJM：抗肿瘤药心脏毒性十五要点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cc11819802a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1537681, encodeId=7fc3153e681f5, content=<a href='/topic/show?id=1f9983082fa' target=_blank style='color:#2F92EE;'>#肿瘤药#</a>, objectTitle=2016MASCC/ESMO共识建议——催吐药风险分类及抗肿瘤药物致吐性评估发布, objectType=article, longId=76273, objectId=3d4be6273e6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3d4be6273e6, replyNumber=0, likeNumber=36, createdTime=2016-09-01, rootId=0, userName=30397608, userId=ed1012894470, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3d4be6273e6, moduleTitle=2016MASCC/ESMO共识建议——催吐药风险分类及抗肿瘤药物致吐性评估发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3d4be6273e6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1537680, encodeId=dc31153e680e1, content=<a href='/topic/show?id=1f9983082fa' target=_blank style='color:#2F92EE;'>#肿瘤药#</a>, objectTitle=未来5年畅销的抗肿瘤药物TOP10, objectType=article, longId=75388, objectId=e37be538834, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e37be538834, replyNumber=0, likeNumber=51, createdTime=2016-08-19, rootId=0, userName=30397608, userId=ed1012894470, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e37be538834, moduleTitle=未来5年畅销的抗肿瘤药物TOP10, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e37be538834)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1537679, encodeId=b765153e679ee, content=<a href='/topic/show?id=1f9983082fa' target=_blank style='color:#2F92EE;'>#肿瘤药#</a>, objectTitle=肿瘤药物研发大潮的驱动力及潜在风险, objectType=article, longId=72150, objectId=121de215014, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=121de215014, replyNumber=0, likeNumber=57, createdTime=2016-07-07, rootId=0, userName=30397608, userId=ed1012894470, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=121de215014, moduleTitle=肿瘤药物研发大潮的驱动力及潜在风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=121de215014)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1537678, encodeId=44e6153e6785b, content=<a href='/topic/show?id=1f9983082fa' target=_blank style='color:#2F92EE;'>#肿瘤药#</a>, objectTitle=ASCO 2016：肿瘤药物的五大趋势, objectType=article, longId=70427, objectId=ea6ee04271c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ea6ee04271c, replyNumber=0, likeNumber=84, createdTime=2016-06-12, rootId=0, userName=30397608, userId=ed1012894470, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ea6ee04271c, moduleTitle=ASCO 2016：肿瘤药物的五大趋势, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ea6ee04271c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1537677, encodeId=e396153e6779f, content=<a href='/topic/show?id=1f9983082fa' target=_blank style='color:#2F92EE;'>#肿瘤药#</a>, objectTitle=沪亚生物国际获复旦大学免疫肿瘤药品专利权——IDO抑制剂被开发用于肿瘤治疗, objectType=article, longId=64946, objectId=290f64946ef, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=290f64946ef, replyNumber=0, likeNumber=67, createdTime=2016-03-18, rootId=0, userName=30397608, userId=ed1012894470, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=290f64946ef, moduleTitle=沪亚生物国际获复旦大学免疫肿瘤药品专利权——IDO抑制剂被开发用于肿瘤治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=290f64946ef)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1537676, encodeId=236e153e6761f, content=<a href='/topic/show?id=1f9983082fa' target=_blank style='color:#2F92EE;'>#肿瘤药#</a>, objectTitle=复旦大学抗肿瘤药物专利“天价”卖给美国公司, objectType=article, longId=64929, objectId=dfc664929a1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dfc664929a1, replyNumber=0, likeNumber=75, createdTime=2016-03-18, rootId=0, userName=30397608, userId=ed1012894470, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dfc664929a1, moduleTitle=复旦大学抗肿瘤药物专利“天价”卖给美国公司, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dfc664929a1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1537675, encodeId=a303153e675ef, content=<a href='/topic/show?id=1f9983082fa' target=_blank style='color:#2F92EE;'>#肿瘤药#</a>, objectTitle=中国抗癌协会肿瘤药物临床研究专业委员会成立, objectType=article, longId=64738, objectId=d00764e3833, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d00764e3833, replyNumber=0, likeNumber=61, createdTime=2016-03-16, rootId=0, userName=30397608, userId=ed1012894470, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d00764e3833, moduleTitle=中国抗癌协会肿瘤药物临床研究专业委员会成立, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d00764e3833)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1537674, encodeId=50b9153e674b5, content=<a href='/topic/show?id=1f9983082fa' target=_blank style='color:#2F92EE;'>#肿瘤药#</a>, objectTitle=JAMA子刊：FDA肿瘤药物批准背后的利益关系, objectType=article, longId=62900, objectId=18cc629003d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=18cc629003d, replyNumber=0, likeNumber=65, createdTime=2016-02-04, rootId=0, userName=30397608, userId=ed1012894470, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=18cc629003d, moduleTitle=JAMA子刊：FDA肿瘤药物批准背后的利益关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=18cc629003d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1537673, encodeId=a33a153e67304, content=<a href='/topic/show?id=1f9983082fa' target=_blank style='color:#2F92EE;'>#肿瘤药#</a>, objectTitle=JAMA Dermat：在美国，局部抗肿瘤药物涨幅近1240%, objectType=article, longId=59536, objectId=03c459536ba, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=03c459536ba, replyNumber=0, likeNumber=84, createdTime=2015-11-28, rootId=0, userName=30397608, userId=ed1012894470, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=03c459536ba, moduleTitle=JAMA Dermat：在美国，局部抗肿瘤药物涨幅近1240%, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=03c459536ba)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1537672, encodeId=57a4153e67279, content=<a href='/topic/show?id=1f9983082fa' target=_blank style='color:#2F92EE;'>#肿瘤药#</a>, objectTitle=抗肿瘤药物尼罗替尼可能会逆转帕金森氏症, objectType=article, longId=57761, objectId=a0445e76182, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a0445e76182, replyNumber=0, likeNumber=74, createdTime=2015-10-26, rootId=0, userName=30397608, userId=ed1012894470, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a0445e76182, moduleTitle=抗肿瘤药物尼罗替尼可能会逆转帕金森氏症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a0445e76182)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

肿瘤药

2020-05-29

30397608 (审核中...)

前往app查看评论内容

#肿瘤药#

CFDA官网干货：抗肿瘤药物临床试验重要终点指标

2017-09-01

30397608 (审核中...)

前往app查看评论内容

#肿瘤药#

2022年畅销的抗肿瘤药物TOP10

2017-06-11

30397608 (审核中...)

前往app查看评论内容

#肿瘤药#

Sci Rep：朱诗国团队提出抗肿瘤药物研发的新思路

2017-05-07

30397608 (审核中...)

前往app查看评论内容

#肿瘤药#

Oncotarget：维生素C抗癌活力竟是肿瘤药物的十倍！

2017-03-22

30397608 (审核中...)

前往app查看评论内容

#肿瘤药#

抗肿瘤药物的时间“罗盘”

2017-03-19

30397608 (审核中...)

前往app查看评论内容

#肿瘤药#

这个肿瘤药那么好，研发公司创始人却被投进大牢！

2017-02-28

30397608 (审核中...)

前往app查看评论内容

#肿瘤药#

【数图说】国内外抗肿瘤药销售市场一览

2017-02-16

30397608 (审核中...)

前往app查看评论内容

#肿瘤药#

Adv Healthc Mater：开发出磁控干细胞用于肿瘤药物靶向输送

2017-01-07

30397608 (审核中...)

前往app查看评论内容

#肿瘤药#

The Lancent oncology：所有仿制的抗肿瘤药都安全吗？

2016-11-11

30397608 (审核中...)

前往app查看评论内容

#肿瘤药#

NEJM：抗肿瘤药心脏毒性十五要点

2016-11-10

30397608 (审核中...)

前往app查看评论内容

#肿瘤药#

2016MASCC/ESMO共识建议——催吐药风险分类及抗肿瘤药物致吐性评估发布

2016-09-01

30397608 (审核中...)

前往app查看评论内容

#肿瘤药#

未来5年畅销的抗肿瘤药物TOP10

2016-08-19

30397608 (审核中...)

前往app查看评论内容

#肿瘤药#

肿瘤药物研发大潮的驱动力及潜在风险

2016-07-07

30397608 (审核中...)

前往app查看评论内容

#肿瘤药#

ASCO 2016：肿瘤药物的五大趋势

2016-06-12

30397608 (审核中...)

前往app查看评论内容

#肿瘤药#

沪亚生物国际获复旦大学免疫肿瘤药品专利权——IDO抑制剂被开发用于肿瘤治疗

2016-03-18

30397608 (审核中...)

前往app查看评论内容

#肿瘤药#

复旦大学抗肿瘤药物专利“天价”卖给美国公司

2016-03-18

30397608 (审核中...)

前往app查看评论内容

#肿瘤药#

中国抗癌协会肿瘤药物临床研究专业委员会成立

2016-03-16

30397608 (审核中...)

前往app查看评论内容

#肿瘤药#

JAMA子刊：FDA肿瘤药物批准背后的利益关系

2016-02-04

30397608 (审核中...)

前往app查看评论内容

#肿瘤药#

JAMA Dermat：在美国，局部抗肿瘤药物涨幅近1240%

2015-11-28

30397608 (审核中...)

前往app查看评论内容

#肿瘤药#

抗肿瘤药物尼罗替尼可能会逆转帕金森氏症

2015-10-26

科室
- - 订阅+
  - 更多科室
工具
服务